IART NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Integra LifeSciences Holdings · Healthcare · Medical Devices

Open interactive chart View report data
Latest close 16.65 USD
-15.9% latest week
Weekly setup

Mixed setup

The weekly trend is active. Price is 22.7% above the Trend Line and sits at 67.4% of its 52-week range. The latest completed week returned -15.9%, after a -7.8% four-week move. The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is bearish with 35/100 conviction, while the latest news-sentiment score is 54/100.

Setup score 54 out of 100
Latest Close 16.65 USD 31 Jul 2026
1W Return -15.9% latest completed week
4W Return -7.8% short-term follow-through
12W Return 19.6% quarterly tape
Trend Breadth 17.3% 9 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 9-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The latest week was a sharp negative move.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -15.9% Latest completed week; four-week move -7.8%. Indicator stack 41/68 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Bearish 35/100 conviction; expected move 23.1%. News sentiment 54/100 58 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 22.7% above the Trend Line and sits at 67.4% of its 52-week range. The latest completed week returned -15.9%, after a -7.8% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.9112-week average 0.57

12-week confirmation

Trend active9/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership11/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.91Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -7.8% over four weeks, 19.6% over 12 weeks, and 35.3% over one year. The current trend has remained active for 9 consecutive weeks.

Performance by holding period

1W-15.9%
4W-7.8%
12W19.6%
26W49.5%
52W35.3%
Active trend streak9 weeks
Active weeks in one year9
Trend breadth17.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.09Latest activity-pressure read.
Pressure change-15.5%Four-week change in activity pressure.
Leadership12.83Latest relative-leadership reading.
RS change-36.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks weakly versus its universe; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 82% Model confidence 78%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength36/100Blend of value, momentum, and quality. Underlying universe rank 65; rank 1 is best.
Value35/100Relative valuation strength. Underlying universe rank 66; rank 1 is best.
Quality17/100Profitability and accounting quality. Underlying universe rank 84; rank 1 is best.
Momentum85/100Medium-term price momentum. Underlying universe rank 16; rank 1 is best.
Growth27/100Revenue and earnings growth. Underlying universe rank 74; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
0.9x
Market value relative to trailing revenue.
EV / EBITDA
-
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
4.6%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
53.2%
Gross profit retained from each unit of revenue.
Operating margin
-26.9%
Operating profit retained from revenue.
Free-cash-flow margin
9.3%
Free cash flow generated from revenue.
Return on invested capital
-11.6%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
1.2%
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-33.5%
Latest one-year free-cash-flow growth.
Piotroski F-score
5/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-0.0%
Net share repurchases relative to market value.
Shareholder yield
-0.0%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-6.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningBearish

IART shows bearish options pressure with a 35/100 conviction score, put-call volume ratio of 2.18, expected move of 23.1%, and Sharemaestro trend signal active.

Conviction35/100
Expected move23.1%
Put/call volume2.18
Pressure-29
Speculation12
Volatility67
Trend agreement52
Open options detail
Insider activity13 / 3

13 acquisitions and 3 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment54/100

Weighted news tone is neutral across 58 relevant articles.

13 positive · 40 neutral · 5 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move23.1%Nearest-chain priced movement where available.
52-week drawdown-18.7%Distance below the 52-week high.
13-week volatility9.0%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher18 of 268 weeks finished lower.
Best week+27.1%Week of 8 May.
Worst week-15.9%Week of 31 Jul.
Latest week-15.9%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains9
Flat weeks0
Modest losses3
Sharp losses5
Recent vol9.0%13-week weekly-return volatility.
Base vol8.3%52-week weekly-return volatility.
Up/down split32/20Count of positive and negative weeks in the 52-week window.
Average skew5.9% / -7.1%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape54/100

Trend, activity pressure, participation, and risk combine to a 54/100 tape read.

 Indicator analysis82/100

Latest 12-week confirmation: trend 9/12, activity pressure 12/12, relative leadership 11/12.

Activity pressure 0.91; No reversal markers Factors40/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 70; Small Cap Core rank 69 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options47/100

IART shows bearish options pressure with a 35/100 conviction score, put-call volume ratio of 2.18, expected move of 23.1%, and Sharemaestro trend signal active.

Bearish · Put-side pressure · Expected move 23.1% Sentiment54/100

Weighted news tone is neutral across 58 relevant articles.

Integra Lifesciences Holdings Corp (IART) Shareholder Structure: Major Shareholders & Institutional Holdings Insiders13 / 3

13 acquisitions and 3 disposals in the latest 180-day insider tape.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 202616.65 USD-15.9%13.57 USD23.00 USD1.0912.837.4MOn
24 Jul 202619.79 USD2.8%13.42 USD23.18 USD1.2135.073.8MOn
17 Jul 202619.25 USD2.4%13.18 USD23.34 USD1.2829.954.9MOn
10 Jul 202618.79 USD4.1%12.96 USD23.51 USD1.3022.434.6MOn
3 Jul 202618.05 USD-3.8%12.78 USD23.66 USD1.2920.083.4MOn
26 Jun 202618.76 USD6.7%12.62 USD23.81 USD1.3425.995.4MOn
19 Jun 202617.58 USD-1.1%12.43 USD23.95 USD1.3013.174.9MOn
12 Jun 202617.77 USD4.6%12.25 USD24.09 USD1.2917.633.8MOn
5 Jun 202616.99 USD5.9%12.05 USD24.24 USD1.3515.224.6MOn
29 May 202616.04 USD6.2%11.88 USD24.39 USD1.403.734.3MOff
22 May 202615.10 USD7.1%11.75 USD24.54 USD1.230.224.7MOff
15 May 202614.10 USD1.3%11.78 USD24.69 USD0.89-5.565.8MOff
8 May 202613.92 USD27.1%11.81 USD24.92 USD0.55-7.5910.2MOff
1 May 202610.95 USD3.6%11.79 USD25.14 USD-0.02-23.704.1MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.